echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Plant Extracts News > New FDA NDI regulations may affect China's extract industry

    New FDA NDI regulations may affect China's extract industry

    • Last Update: 2011-10-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The latest NDI guidance draft issued by FDA redefines the Dietary Supplement Health Education Act (DSHEA) of 1994 Some natural ingredient supplements that indicate health claims and have obvious health effects and have entered the market may be forced to be sold as prescription drugs In this way, the opportunity for consumers to purchase high-quality active supplements will be significantly reduced, and the cost of taking dietary supplements will be correspondingly increased DHA is the first batch of nutrients controlled by FDA At present, DHA / ω - 3 fatty acids can reduce the level of triglycerides in the treatment products in the U.S market, because there are sufficient data proving that DHA / ω - 3 fatty acids can reduce the level of triglycerides FDA and the pharmaceutical industry are aware that therapeutic dietary supplements have significant effects and no serious side effects Taking DHA as an example, GlaxoSmithKline has developed a prescription drug for DHA fish oil, which can be sold for about 189 US dollars a month; in the market of dietary supplements, the equivalent high-quality molecular distillation of DHA can be sold for 35 US dollars a month Industry insiders said that not only DHA, curcumin and resveratrol will also be taken over by pharmaceutical companies, but also hundreds of other nutrients and plants will inevitably have such results If FDA finally implements this strategy, thousands of products currently on the market are likely to be identified as "substandard drugs" and removed from the market Finally, the strength and profit margin of pharmaceutical enterprises will be larger, and the food supplement industry will be significantly reduced, and the time of drug approval will be extended indefinitely However, amid mounting opposition from U.S authorities, the U.S FDA decided to extend the deadline for public consultation on the draft guidelines for new dietary supplements from October to December this year Although the NDI laws and regulations have not been settled, they have attracted extensive attention of Chinese enterprises What impact will NDI regulations have on the plant extract industry in China? It is reported that this will be discussed at the 2011 China plant extract industry international competitiveness promotion forum held on October 27-28.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.